Best Antibiotic for Pharyngitis
Penicillin or amoxicillin is the best antibiotic for acute bacterial pharyngitis, given for 10 days. This recommendation is based on their narrow spectrum of activity, proven efficacy, excellent safety profile, low cost, and the fact that penicillin-resistant Group A Streptococcus (GAS) has never been documented 1.
First-Line Treatment for Non-Allergic Patients
The IDSA guideline provides a strong, high-quality evidence recommendation that penicillin or amoxicillin should be the drug of choice for patients without penicillin allergy 1. The rationale is compelling:
- Narrow antimicrobial spectrum minimizes disruption of normal flora and reduces selection pressure for resistant organisms
- No documented resistance - GAS has never developed resistance to penicillin despite decades of use 1
- Low cost compared to broader-spectrum alternatives
- Minimal adverse effects compared to other antibiotic classes
- Proven efficacy in preventing both suppurative complications and acute rheumatic fever 2
Practical Considerations
Amoxicillin is often preferred over penicillin V in young children because the suspension tastes better, improving adherence 1. The efficacy is equivalent. Once-daily amoxicillin dosing (50 mg/kg, maximum 1000 mg) for 10 days has been shown effective and may enhance compliance 1.
Duration matters: Most oral antibiotics require the full 10-day course to achieve maximal pharyngeal eradication of GAS 1. Shorter courses risk treatment failure and inadequate prevention of complications.
Treatment for Penicillin-Allergic Patients
For patients with penicillin allergy, the treatment algorithm depends on the type of allergic reaction 1:
Non-Anaphylactic Allergy
Anaphylactic-Type Hypersensitivity
Cephalosporins should not be used in patients with immediate anaphylactic reactions to penicillin 2. Alternatives include:
- Clindamycin for 10 days (resistance rate ~1% in the US) 1, 2
- Clarithromycin for 10 days
- Azithromycin for 5 days
Critical Caveat: Azithromycin Concerns
Azithromycin should be avoided when other options are available. Recent high-quality evidence from 2026 demonstrates that azithromycin has:
- Inferior early bacterial eradication compared to penicillin V (OR: 0.53; 95% CI: 0.32-0.90) 3
- Suboptimal late bacterial eradication (OR: 0.38; 95% CI: 0.25-0.62) 3
- Higher late recurrence rates 3
- Increased adverse events 3
Additionally, macrolide resistance rates among pharyngeal GAS isolates in the United States have reached approximately 5-8%, with some areas showing higher rates 2, 4. This makes macrolides less reliable than they once were.
Antibiotics to Avoid
The following should never be used for GAS pharyngitis 2:
- Tetracyclines - high prevalence of resistant strains
- Sulfonamides and trimethoprim-sulfamethoxazole - do not eradicate GAS
- Older fluoroquinolones (e.g., ciprofloxacin) - limited activity against GAS
- Newer fluoroquinolones (e.g., levofloxacin, moxifloxacin) - unnecessarily broad spectrum despite in vitro activity
Emerging Evidence on Cephalosporins
A 2026 network meta-analysis found that certain cephalosporins demonstrated superior efficacy compared to penicillin V 3:
- Cefdinir showed significantly better early bacterial eradication (OR: 3.09) and early clinical response (OR: 2.01)
- Cefpodoxime proxetil demonstrated better early bacterial eradication (OR: 2.58)
- Cefuroxime axetil showed better early clinical response (OR: 2.14)
However, this does not change the first-line recommendation. Penicillin and amoxicillin remain preferred to support antimicrobial stewardship principles, given their narrow spectrum and the absence of resistance. Cefdinir represents an effective alternative when penicillin is not suitable 3.
Important Clinical Pitfalls
Do not prescribe antibiotics without confirming bacterial pharyngitis. Only 10% of adults and 15-30% of children with sore throat have GAS pharyngitis 4, 5. Use clinical decision rules (Centor, McIsaac, FeverPAIN scores) and confirm with rapid antigen detection testing or throat culture before prescribing 1, 4, 6.
Avoid amoxicillin-clavulanate as initial therapy - the addition of clavulanate provides no benefit for GAS pharyngitis and unnecessarily broadens the spectrum 7.
Do not routinely treat asymptomatic household contacts - this is not warranted given the self-limited nature of GAS pharyngitis and concerns about antibiotic resistance 1.